Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Protocol violations in Colombian ivermectin study compromise results

Written by | 25 Mar 2021

Interview and article by Christine Clark Dr David Scheim explains how multiple protocol violations and widespread use of over-the-counter ivermectin could have compromised the results of a recent… read more.

Real world evidence from Israeli Ministry of Health analysis confirms high effectiveness of the Pfizer-BioNTech COVID 19 vaccine

Written by | 24 Mar 2021

The Israel Ministry of Health (MoH), Pfizer Inc. and BioNTech SE announced real-world evidence demonstrating dramatically lower incidence rates of COVID-19 disease in individuals fully vaccinated with the… read more.

Ivermectin in Peru – results that save lives

Written by | 24 Mar 2021

Interview and article by Christine Clark Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as… read more.

Analysis confirms 14 fold reduction in deaths with Ivermectin treatment in Peru

Written by | 23 Mar 2021

Interview and article by Christine Clark Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a… read more.

UK and EU regulatory agencies confirm COVID-19 Vaccine AstraZeneca is safe and effective

Written by | 22 Mar 2021

The Medicines Health Regulatory Authority (MHRA) and European Medicines Agency (EMA) reaffirmed the benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh the risks.

Interim SAGE/WHO recommendation supporting the use of the Johnson & Johnson COVID-19 Vaccine

Written by | 18 Mar 2021

Johnson & Johnson welcomes the interim recommendation by the Strategic Advisory Group of Experts (SAGE) on Immunization for the World Health Organization (WHO) supporting the use of Johnson… read more.

EU grants conditional approval for single-dose COVID-19 vaccine JNJ 78436735 – Johnson & Johnson

Written by | 18 Mar 2021

Johnson & Johnson announced that the European Commission (EC) has granted a Conditional Marketing Authorization (CMA) for its single-dose COVID-19 vaccine JNJ 78436735, developed by the Janssen Pharmaceutical… read more.

Health Canada approves COVID 19 AstraZeneca vaccine to prevent COVID-19

Written by | 17 Mar 2021

Health Canada has approved the Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19) and a related shot by the Serum Institute of India for use in Canada.

Update on the safety of COVID-19 Vaccine AstraZeneca

Written by | 16 Mar 2021

Following a recent concern raised around thrombotic events, AstraZeneca would like to offer its reassurance on the safety of its COVID-19 vaccine based on clear scientific evidence. Safety… read more.

EMA backs six new medicines

Written by | 14 Mar 2021

Article written by Gary Finnegan. The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended six medicines for approval at its February 2021 meeting:

International agencies coordinate regulation of COVID-19 vaccines and medicines

Written by | 13 Mar 2021

Article written by Gary Finnegan. Regulators around the globe are aligning their approaches to the approval of vaccines and medicines against COVID-19. Closer cooperation is seen as crucial… read more.

EMA plans rapid approval of vaccines against COVID-19 variants

Written by | 12 Mar 2021

Article written by Gary Finnegan. New COVID-19 vaccines against variants of the virus could be approved much more quickly than the first generation of jabs. The European Medicines… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.